ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Andrew Bascand: Investing in new technology"
Episode Synopsis
Andrew Bascand, Managing Director of Harbour Asset Management joins me to discuss new findings of the GLP-1 drug class, which has predominantly been used to treat type 2 diabetes but has captured notable mindshare with healthcare specialists and macro investors. Listen in for your chance to get ahead of the markets. LISTEN ABOVESee omnystudio.com/listener for privacy information.
More episodes of the podcast Smart Money
Andrew Bascand: The OCR won't solve anything
24/08/2025
In God we trust